RCVS: The Rational Approach to Diagnosis and Treatment


Phase 4 Results N/A

Summary of Purpose

This is a randomized clinical trial of short-acting nimodipine versus twice daily extended release verapamil to treat patients presenting with Reversible Cerebral Vasoconstriction Syndrome (RCVS).

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 21 August 2017.

1 Jul 2017 8 May 2017 31 May 2019 31 May 2019 1 Aug 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available